SEC Form 4 · accession 0001209191-15-006347
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Watkins
Director
Period of report
Aug 14, 2014
Accepted (ET)
Jan 26, 2015 · 9:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 14, 2014 | P | 6,000 | $9.76 | A | 6,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The securities reflected in this report represent securities of Horizon Pharma, Inc., a Delaware corporation. Such securities subsequently converted to securities of Horizon Pharma plc.